(NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent ® (dupilumab) in adults and adolescents with moderate-to-severe atopic ...

Psychedelics research gains support from the Trump administration for treating PTSD and mental health conditions, with Veterans Affairs exploring treatments that show promise in clinical trials.

Insomnia affects millions and is closely linked to heart and mental health. Here's what we know about causes, treatments, and ...

The HHS secretary said people should have access to experimental therapies including unregulated uses of stem cells. But some ...

Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...

AI therapy apps promise easy access to mental health care. But convenience comes with hidden costs we're only just beginning ...

CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

This June during Alzheimer’s & Brain Awareness Month, the Alzheimer’s Association is encouraging all Americans to take charge ...

The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

Alzheimer's disease, marked by memory loss, trouble concentrating and thinking, and changes in personality and behavior, ...

New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...